Kaleido Biosciences Stock Z Score
KLDODelisted Stock | USD 0.01 0.00 0.00% |
Kaleido |
Kaleido Biosciences Company Z Score Analysis
Kaleido Biosciences' Z-Score is a simple linear, multi-factor model that measures the financial health and economic stability of a company. The score is used to predict the probability of a firm going into bankruptcy within next 24 months or two fiscal years from the day stated on the accounting statements used to calculate it. The model uses five fundamental business ratios that are weighted according to algorithm of Professor Edward Altman who developed it in the late 1960s at New York University..
Current Kaleido Biosciences Z Score | -6.3 |
Most of Kaleido Biosciences' fundamental indicators, such as Z Score, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Kaleido Biosciences is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
| |||||||
| |||||||
| |||||||
| |||||||
|
To calculate a Z-Score, one would need to know a company's current working capital, its total assets and liabilities, and the amount of its latest earnings as well as earnings before interest and tax. Z-Scores can be used to compare the odds of bankruptcy of companies in a similar line of business or firms operating in the same industry. Companies with Z-Scores above 3.1 are generally considered to be stable and healthy with a low probability of bankruptcy. Scores that fall between 1.8 and 3.1 lie in a so-called 'grey area,' with scores of less than 1 indicating the highest probability of distress. Z Score is a used widely measure by financial auditors, accountants, money managers, loan processors, wealth advisers, and day traders. In the last 25 years, many financial models that utilize z-scores proved it to be successful as a predictor of corporate bankruptcy.
CompetitionBased on the company's disclosures, Kaleido Biosciences has a Z Score of -6.3. This is 193.33% lower than that of the Pharmaceuticals sector and 288.62% lower than that of the Health Care industry. The z score for all United States stocks is 172.25% higher than that of the company.
Kaleido Z Score Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Kaleido Biosciences' direct or indirect competition against its Z Score to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Kaleido Biosciences could also be used in its relative valuation, which is a method of valuing Kaleido Biosciences by comparing valuation metrics of similar companies.Kaleido Biosciences is currently under evaluation in z score category among its peers.
Kaleido Fundamentals
Return On Equity | -5.81 | ||||
Return On Asset | -1.0 | ||||
Operating Margin | (79.28) % | ||||
Current Valuation | (16.73 M) | ||||
Shares Outstanding | 42.62 M | ||||
Shares Owned By Insiders | 0.73 % | ||||
Shares Owned By Institutions | 0.36 % | ||||
Number Of Shares Shorted | 2.34 M | ||||
Price To Earning | (1.45) X | ||||
Price To Book | 0 X | ||||
Price To Sales | 0.04 X | ||||
Revenue | 1.1 M | ||||
Gross Profit | (66.7 M) | ||||
EBITDA | (85.09 M) | ||||
Net Income | (90.29 M) | ||||
Cash And Equivalents | 38.47 M | ||||
Cash Per Share | 0.90 X | ||||
Total Debt | 5.55 M | ||||
Debt To Equity | 2.04 % | ||||
Current Ratio | 1.42 X | ||||
Book Value Per Share | 0.25 X | ||||
Cash Flow From Operations | (77.09 M) | ||||
Short Ratio | 29.34 X | ||||
Earnings Per Share | (2.16) X | ||||
Target Price | 22.0 | ||||
Number Of Employees | 76 | ||||
Beta | 0.42 | ||||
Market Capitalization | 421.96 K | ||||
Total Asset | 50.14 M | ||||
Retained Earnings | (197.63 M) | ||||
Working Capital | 62.54 M | ||||
Current Asset | 72.93 M | ||||
Current Liabilities | 10.39 M | ||||
Z Score | -6.3 | ||||
Net Asset | 50.14 M |
About Kaleido Biosciences Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Kaleido Biosciences's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Kaleido Biosciences using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Kaleido Biosciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment. You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.
Other Consideration for investing in Kaleido Pink Sheet
If you are still planning to invest in Kaleido Biosciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Kaleido Biosciences' history and understand the potential risks before investing.
Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities |